Citizens Financial Group »

Eliem Therapeutics shares owned by Citizens Financial Group

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Citizens Financial Group from 13F filings

Historical chart of Citizens Financial Group investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Citizens Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Citizens Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $93k 46k 2.01

More positions owned by Citizens Financial Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Facebook Cl A (META)
Ishares Core Msci Emkt (IEMG)

View all positions for Citizens Financial Group

Top funds holding Eliem Therapeutics

RA Capital Management
Vanguard Group
Affinity Asset Advisors
Kynam Capital Management
Tang Capital Management
BlackRock
Peapod Lane Capital
Cantor Fitzgerald, L. P.
Renaissance Technologies
Deep Track Capital
Alyeska Investment Group
Millennium Management
Nan Fung Trinity
Sphera Funds Management
UBS Group

View all funds holding Eliem Therapeutics